Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The closing price of Replimune Group Inc (NASDAQ: REPL) was $8.45 for the day, up 0.36% from the previous closing price of $8.42. In other words, the price has increased by $0.36 from its previous closing price. On the day, 0.95 million shares were traded. REPL stock price reached its highest trading level at $8.55 during the session, while it also had its lowest trading level at $8.31.
Ratios:
Our analysis of REPL’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 6.31 and its Current Ratio is at 6.31. In the meantime, Its Debt-to-Equity ratio is 0.29 whereas as Long-Term Debt/Eq ratio is at 0.27.
On October 27, 2025, H.C. Wainwright Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $12.
Wedbush Upgraded its Neutral to Outperform on October 20, 2025, while the target price for the stock was maintained at $18.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 09 ’25 when Dhingra Kapil sold 3,169 shares for $10.40 per share. The transaction valued at 32,958 led to the insider holds 0 shares of the business.
Kapil Dhingra bought 3,164 shares of REPL for $32,842 on Dec 09 ’25. On Dec 02 ’25, another insider, Patel Sushil, who serves as the Chief Executive Officer of the company, sold 10,000 shares for $11.13 each. As a result, the insider received 111,300 and left with 333,576 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, REPL now has a Market Capitalization of 662846144 and an Enterprise Value of 415526176.
Stock Price History:
The Beta on a monthly basis for REPL is 0.74, which has changed by -0.26973116 over the last 52 weeks, in comparison to a change of 0.16623151 over the same period for the S&P500. Over the past 52 weeks, REPL has reached a high of $14.80, while it has fallen to a 52-week low of $2.68. The 50-Day Moving Average of the stock is -11.35%, while the 200-Day Moving Average is calculated to be 6.07%.
Shares Statistics:
REPL traded an average of 4.04M shares per day over the past three months and 1269620 shares per day over the past ten days. A total of 78.40M shares are outstanding, with a floating share count of 71.45M. Insiders hold about 8.91% of the company’s shares, while institutions hold 100.39% stake in the company. Shares short for REPL as of 1765756800 were 14761596 with a Short Ratio of 3.65, compared to 1763078400 on 16697152. Therefore, it implies a Short% of Shares Outstanding of 14761596 and a Short% of Float of 35.189998.
Earnings Estimates
Currently, 5.0 analysts are dedicated to thoroughly evaluating and rating the performance of Replimune Group Inc (REPL) in the stock market.The consensus estimate for the next quarter is -$0.84, with high estimates of -$0.69 and low estimates of -$0.95.
Analysts are recommending an EPS of between -$2.89 and -$3.73 for the fiscal current year, implying an average EPS of -$3.37. EPS for the following year is -$2.06, with 4.0 analysts recommending between -$1.04 and -$2.86.
